€52.10
2.86% yesterday
Borsa Italiana, Nov 22, 05:39 pm CET
ISIN
IT0003828271
Symbol
REC
Sector
Industry

Recordati Stock price

€52.10
-1.25 2.34% 1M
+2.94 5.98% 6M
+3.27 6.70% YTD
+7.71 17.37% 1Y
-4.18 7.43% 3Y
+14.68 39.23% 5Y
+38.38 279.74% 10Y
Borsa Italiana, Closing price Fri, Nov 22 2024
+1.45 2.86%
ISIN
IT0003828271
Symbol
REC
Sector
Industry

Key metrics

Market capitalization €10.75b
Enterprise Value €12.07b
P/E (TTM) P/E ratio 25.38
EV/FCF (TTM) EV/FCF 24.28
EV/Sales (TTM) EV/Sales 5.32
P/S ratio (TTM) P/S ratio 4.74
P/B ratio (TTM) P/B ratio 5.72
Dividend yield 2.30%
Last dividend (FY23) €1.20
Revenue growth (TTM) Revenue growth 11.68%
Revenue (TTM) Revenue €2.27b
EBIT (operating result TTM) EBIT €632.80m
Free Cash Flow (TTM) Free Cash Flow €496.97m
Cash position €235.02m
EPS (TTM) EPS €2.05
P/E forward 23.06
P/S forward 4.62
EV/Sales forward 5.19
Show more

Is Recordati a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 6,883 stocks worldwide.

Recordati Stock Analysis

Unlock Scores for Free

Analyst Opinions

11 Analysts have issued a Recordati forecast:

5x Buy
45%
5x Hold
45%
1x Sell
9%

Analyst Opinions

11 Analysts have issued a Recordati forecast:

Buy
45%
Hold
45%
Sell
9%

Financial data from Recordati

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Sep '24
+/-
%
2,269 2,269
12% 12%
100%
- Direct Costs 725 725
14% 14%
32%
1,544 1,544
10% 10%
68%
- Selling and Administrative Expenses 472 472
3% 3%
21%
- Research and Development Expense 278 278
13% 13%
12%
793 793
15% 15%
35%
- Depreciation and Amortization 160 160
15% 15%
7%
EBIT (Operating Income) EBIT 633 633
15% 15%
28%
Net Profit 423 423
13% 13%
19%

In millions EUR.

Don't miss a Thing! We will send you all news about Recordati directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

Company Profile

Recordati SpA engages in the research, development, manufacturing, and marketing of pharmaceuticals. It operates through the following segments: Specialty & Primary Care and Rare Diseases Pharmaceuticals. The Specialty & Primary Care segment is related to pharmaceutical chemicals business. The Rare Diseases Pharmaceuticals segment, which relates to the Rare Diseases treatment. The company was founded by Giovanni Recordati in 1926 and is headquartered in Milan, Italy.

Head office Italy
CEO Robert Koremans
Employees 4,455
Founded 1996
Website www.recordati.it

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today